Literature DB >> 11012875

Thirteen novel mutations of the replicated region of PKD1 in an Asian population.

B Phakdeekitcharoen1, T J Watnick, C Ahn, D Y Whang, B Burkhart, G G Germino.   

Abstract

BACKGROUND: Mutations of PKD1 are thought to account for approximately 85% of all mutations in autosomal dominant polycystic kidney disease (ADPKD). The search for PKD1 mutations has been hindered by both its large size and complicated genomic structure. To date, few mutations that affect the replicated segment of PKD1 have been described, and virtually all have been reported in Caucasian patients.
METHODS: In the present study, we have used a long-range polymerase chain reaction (PCR)-based strategy previously developed by our laboratory to analyze exons in the replicated region of PKD1 in a population of 41 unrelated Thai and 6 unrelated Korean families with ADPKD. We have amplified approximately 3.5 and approximately 5 kb PKD1 gene-specific fragments (5'MR and 5'LR) containing exons 13 to 15 and 15 to 21 and performed single-stand conformation analysis (SSCA) on nested PCR products.
RESULTS: Nine novel pathogenic mutations were detected, including six nonsense and three frameshift mutations. One of the deletions was shown to be a de novo mutation. Four potentially pathogenic variants, including one 3 bp insertion and three missense mutations, were also discovered. Two of the nonconservative amino acid substitutions were predicted to disrupt the three-dimensional structure of the PKD repeats. In addition, six polymorphisms, including two missense and four silent nucleotide substitutions, were identified. Approximately 25% of both the pathogenic and normal variants were found to be present in at least one of the homologous loci.
CONCLUSION: To our knowledge, this is the first report of mutation analysis of the replicated region of PKD1 in a non-Caucasian population. The methods used in this study are widely applicable and can be used to characterize PKD1 in a number of ethnic groups using DNA samples prepared using standard techniques. Our data suggest that gene conversion may play a significant role in producing variability of the PKD1 sequence in this population. The identification of additional mutations will help guide the study of polycystin-1 and better help us to understand the pathophysiology of this common disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012875     DOI: 10.1046/j.1523-1755.2000.00302.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease.

Authors:  Meiling Jin; Yuansheng Xie; Zhiqiang Chen; Yujie Liao; Zuoxiang Li; Panpan Hu; Yan Qi; Zhiwei Yin; Qinggang Li; Ping Fu; Xiangmei Chen
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

2.  Genetics and phenotypic characteristics of autosomal dominant polycystic kidney disease in Finns.

Authors:  Paula Peltola; Anne Lumiaho; Raija Miettinen; Jussi Pihlajamäki; Richard Sandford; Markku Laakso
Journal:  J Mol Med (Berl)       Date:  2005-03-17       Impact factor: 4.599

3.  Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications.

Authors:  S Rossetti; L Strmecki; V Gamble; S Burton; V Sneddon; B Peral; S Roy; A Bakkaloglu; R Komel; C G Winearls; P C Harris
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

4.  Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors:  Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

5.  Identification of novel mutations in Chinese Hans with autosomal dominant polycystic kidney disease.

Authors:  Chaowen Yu; Yuan Yang; Lin Zou; Zhangxue Hu; Jing Li; Yunqiang Liu; Yongxin Ma; Mingyi Ma; Dan Su; Sizhong Zhang
Journal:  BMC Med Genet       Date:  2011-12-20       Impact factor: 2.103

6.  Naturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains.

Authors:  Liang Ma; Meixiang Xu; Julia R Forman; Jane Clarke; Andres F Oberhauser
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

7.  Novel and de novo PKD1 mutations identified by multiple restriction fragment-single strand conformation polymorphism (MRF-SSCP).

Authors:  Wanna Thongnoppakhun; Chanin Limwongse; Kriengsak Vareesangthip; Chintana Sirinavin; Duangkamon Bunditworapoom; Nanyawan Rungroj; Pa-thai Yenchitsomanus
Journal:  BMC Med Genet       Date:  2004-02-03       Impact factor: 2.103

8.  Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next-generation sequencing technology.

Authors:  Tao Wang; Qinggang Li; Shunlai Shang; Guangrui Geng; Yuansheng Xie; Guangyan Cai; Xiangmei Chen
Journal:  Mol Genet Genomic Med       Date:  2019-05-06       Impact factor: 2.183

9.  Identification of missense and synonymous variants in Iranian patients suffering from autosomal dominant polycystic kidney disease.

Authors:  Fatemeh Khadangi; Adam Torkamanzehi; Mohammad Amin Kerachian
Journal:  BMC Nephrol       Date:  2020-09-21       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.